Somatostatin analogs: does pharmacology impact antitumor efficacy?
Mounira Chalabi(Université Toulouse III - Paul Sabatier), Corinne Bousquet(Centre National de la Recherche Scientifique), Philippe Caron(Centre de Recherche en Cancérologie de Toulouse), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Camille Duluc(Inserm), Julie Guillermet‐Guibert(Centre National de la Recherche Scientifique), Delphine Vezzosi(Centre de Recherche en Cancérologie de Toulouse)
Cited by 97
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284